Does LMA Instead of ET Tube Affect Incidence of Postoperative Vomiting in Children Undergoing Strabismus Correction?
|ClinicalTrials.gov Identifier: NCT00338559|
Recruitment Status : Completed
First Posted : June 20, 2006
Last Update Posted : December 3, 2014
|Condition or disease||Phase|
The child will be checked by the study doctor to determine if he/she qualifies to be part of the study. The study doctor may not want the child to take part in this study if he/she is currently in another research study; or if the child has been in any other research study within the last 30 days, or if the child is extremely obese, or has reflux or another GI problem.
If the child qualifies for the study, he/she will receive routine general anesthesia. For airway management, the child will have either a LMA or ET tube. The child has an equal chance of receiving either one of these airways devices, much like the coin flip.
After surgery, the child will be transferred to the recovery room (PACU). If the child vomits in PACU, he/she will receive rescue medication, which can be repeated if the need arises.
A research coordinator will call the parents the following day to find out whether the child vomited after leaving the hospital, in the car or at home, for any complications and receiving any medications.
|Study Type :||Observational|
|Actual Enrollment :||71 participants|
|Official Title:||Does Using Laryngeal Mask Airway (LMA) Instead of an Endotracheal Tube (ET Tube) Affect the Incidence of Postoperative Vomiting in Children Undergoing Strabismus Correction? - An Observational Study|
|Study Start Date :||May 2006|
|Primary Completion Date :||November 2013|
|Study Completion Date :||November 2013|
Patients in which laryngeal mask airway (LMA) is used.
Patients in which endotracheal tube (ET) is used.
- Numbers of the patients that will develop postoperative vomiting in children undergoing strabismus correction [ Time Frame: 2 days ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00338559
|United States, Texas|
|Memorial Hermann Hospital|
|Houston, Texas, United States, 77030|
|Principal Investigator:||Samia N Khalil, MD||University of Texas HSC at Houston|